Last modified by ddiadm - 3 years ago

Mark Miedel, PhD

Research Assistant Professor, Liver MicroPhysiology Systems, Drug Discovery Institute

The goal of my research is to examine the impact of the tumor microenvironment on distinct metastatic phenotypes that are associated with the progression of different cancer types. I have a broad background in cell biology, with specific training and expertise in key research areas for this application. I am a Research Assistant Professor at the Drug Discovery Institute at the University of Pittsburgh where I am involved in both the metastatic breast cancer and melanoma programs. Using the liver MPS platform, I aim to identify unique phenotypes associated with the liver microenvironment in both melanoma and breast cancer to serve as targetable dependencies that will lead to therapeutic treatments.


Primary Address
WordPress Image Lightbox Plugin